Guidelines for Managing HF in Diabetes, Cardiorenal, and Metabolic Conditions
Practice guidelines have been developed regarding management of patients with heart failure and diabetes, cardiorenal, and/or metabolic conditions.
Practice guidelines have been developed regarding management of patients with heart failure and diabetes, cardiorenal, and/or metabolic conditions.
In this fifth update to the living guidelines on drugs for the treatment of COVID-19, the World Health Organization analyzed results of clinical trials that assessed the effects of casirivimab-imdevimab and corticosteroids in patients with severe and non-severe disease.